VEEV logo

VEEV
Veeva Systems Inc - Ordinary Shares - Class A

9,499
Mkt Cap
$26.14B
Volume
2.02M
52W High
$310.50
52W Low
$148.05
PE Ratio
29.57
VEEV Fundamentals
Price
$160.17
Prev Close
$158.27
Open
$159.28
50D MA
$168.10
Beta
0.78
Avg. Volume
2.13M
EPS (Annual)
$5.44
P/B
3.64
Rev/Employee
$403,041.25
$27,588.67
Loading...
Loading...
News
all
press releases
Veeva Systems (VEEV) Stock Slides as Market Rises: Facts to Know Before You Trade
Veeva Systems (VEEV) closed the most recent trading day at $158.27, moving 4.06% from the previous trading session.
News Placeholder
More News
News Placeholder
Veeva Systems (VEEV) Rises Yet Lags Behind Market: Some Facts Worth Knowing
The latest trading day saw Veeva Systems (VEEV) settling at $164.96, representing a +1.01% change from its previous close.
News Placeholder
Veeva Systems' RTSM Momentum Signals Another Long-Term Growth Driver
VEEV benefits from RTSM traction with major pharma wins, strengthening its clinical software strategy and long-term R&D growth outlook.
News Placeholder
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
OPRX's shares slid 30% in a month as MFN pricing and cautious pharma spending hit revenue, even as DAAP growth and EBITDA surged.
News Placeholder
Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
News Placeholder
Is Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
News Placeholder
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
OptimizeRx expands DSP integration to unlock scalable EHR ad campaigns and boost inventory use despite lowering 2026 revenue guidance.
News Placeholder
Veeva Systems Expands AI and Vault CRM Momentum: Time to Buy or Hold?
VEEV expands Vault CRM adoption and AI capabilities with Roche and BioMarin partnerships as life sciences firms modernize workflows.
News Placeholder
Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial
Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial PR...
News Placeholder
Veeva Systems (VEEV) Stock Falls Amid Market Uptick: What Investors Need to Know
Veeva Systems (VEEV) closed the most recent trading day at $156.33, moving 1.94% from the previous trading session.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available